News
Select Category
| All Entries | New Antibodies | Research News | About antibodies-online.com |
Cancer Research Global Summit
The Future of Cancer Therapeutics: Accelerating Progress at the Molecular Level. August 16th -17th 2011, London UK.
The abstract submission deadline for the Cancer Research Summit in London is the August 5th. Abstracts can be submitted for the oral presentation session, for presentations of typically 35-45 minutes length. Please email sabrina.daw@appelconsulting.co.uk. For more information on the scope of topics please visit the Cancer Research Global Summit webpage.
-

31.05.2012 Next-Generation Sequencing - A data interpretation and analytical perspective -

04.05.2012 Entry at Linscott's Directory -

30.04.2012 Conference: SMi present their 3rd annual Biosimilars and Biobetters conference -

20.04.2012 BioChina International 2012-Biopharma and Bioprocessing Congress -

01.03.2012 4th Next Generation Sequencing Congress -

01.03.2012 Biopharma Asia Congress -

01.03.2012 10th Annual Pharma IT Congress -

01.03.2012 2nd Annual Vaccines Congress -

01.03.2012 5th Annual Proteins Congress -

01.03.2012 Oncology Clinical Development Congress -

01.03.2012 2nd Oncology Biomarkers Congress -

01.03.2012 Next Generation Sequencing Asia Congress -

01.03.2012 Clinical Trials Leaders Summit -

01.03.2012 Drug Discovery & Development Leaders Summit -

09.02.2012 Conference: ICNBS Egypt 2012 -

02.02.2012 Heidelberg Forum for Young Life Scientists -

12.01.2012 BioChina International 2012 -

12.01.2012 Biomanufacturing Summit 2012 -

06.01.2012 2nd Annual International Conference on Advances in Biotechnology (BIOTECH 2012) -

16.12.2011 Conference: 2nd annual Clinical Trials in Oncology -

16.12.2011 Conference: 5th Annual CEE & CIS Clinical Trials Forum -

23.11.2011 BioPharma Asia Convention 2012 -

28.10.2011 2nd World Congress on Analytical and Bioanalytical Techniques -

27.10.2011 2nd Annual Clinical Trials in Oncology Conference -

27.10.2011 Conference: Data Management in Clinical Trials

